e8vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 19, 2009
CELANESE CORPORATION
(Exact Name of Registrant as specified in its charter)
| |
|
|
|
|
| DELAWARE
|
|
001-32410
|
|
98-0420726 |
| |
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.) |
1601 West LBJ Freeway, Dallas, Texas 75234-6034
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (972) 443-4000
Not Applicable
(Former name or former address, if changed since last report):
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
| Item 2.06 |
|
Material Impairments |
On January 19, 2009, Celanese Corporation (the “Company”) concluded that certain fixed
production assets were impaired during the fourth quarter of 2008 associated with the potential
closure of the Company’s acetic acid and vinyl acetate monomer (VAM) production facility in
Pardies, France, and its VAM production unit in Cangrejera, Mexico and certain other actions the Company is
considering. The non-cash charge related to the impairment of fixed assets is in the range of $90
to $100 million.
The
Company anticipates that approximately $6 million of this
impairment charge will be future cash expenditures.
On January 21, 2009, the Company issued a press release announcing that it was assessing the
potential closure of acetic acid and VAM production in Pardies, France and VAM production in
Cangrejera, Mexico. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
|
|
|
| Item 9.01 |
|
Financial Statements and Exhibits. |
(d) Exhibits
| |
|
|
|
|
| Exhibit Number |
|
Description |
| |
|
|
|
|
| 99.1 |
|
|
|
Press Release dated January 21, 2009 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
CELANESE CORPORATION
|
|
| |
By: |
/s/ Miguel A. Desdin
|
|
| |
|
Name: |
Miguel A. Desdin |
|
| |
|
Title: |
Vice President and Controller |
|
| |
|
|
|
|
| |
|
|
|
|
| Date: January 21, 2009 |
|
|
|
|
Exhibit Index
| |
|
|
|
|
| Exhibit Number |
|
Description |
| |
|
|
|
|
| |
99.1 |
|
|
Press Release dated January 21, 2009 |